MIMEDX Announces Favorable Ruling in Putative Securities Class Action Case
July 11 2023 - 8:30AM
MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today
announced that the Eleventh Circuit Court of Appeals affirmed the
dismissal of the putative securities class action lawsuit brought
against the Company and others in 2019. In the action, the
plaintiff claimed that the Company violated federal securities
laws. The case was on appeal from the United States District Court
for the Northern District of Georgia.
William “Butch” Hulse, MIMEDX General Counsel
and Chief Administrative Officer, stated, “We are pleased with the
Court’s decision to affirm the dismissal. As an organization
focused on improving patient care, we look forward to driving
continued innovation in the growing markets we serve.”
About MIMEDXMIMEDX is a pioneer
and leader focused on helping humans heal. With more than a decade
of helping clinicians manage chronic and other hard-to-heal wounds,
MIMEDX is dedicated to providing a leading portfolio of products
for applications in the wound care, burn, and surgical sectors of
healthcare. The Company’s vision is to be the leading global
provider of healing solutions through relentless innovation to
restore quality of life. For additional information, please visit
www.mimedx.com.
Contact:Matt NotarianniInvestor
Relations470-304-7291mnotarianni@mimedx.com
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From Apr 2024 to May 2024
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From May 2023 to May 2024